Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Molecular Cancer Therapeutics|January 2, 2015
A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodiesXuejun Fan, Randall J Brezski, Hui Deng, et al.Science Translational Medicine|January 18, 2019
Identification of biologic agents to neutralize the bicomponent leukocidins of <i>Staphylococcus aureus</i>Rita Chan, Peter T Buckley, Aidan O'Malley, et al.The Journal of Biological Chemistry|August 30, 2013
Engineered protease-resistant antibodies with selectable cell-killing functionsMichelle Kinder, Allison R Greenplate, Katharine D Grugan, et al.The Journal of Biological Chemistry|April 11, 2021
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and METJoost Neijssen, Rosa M F Cardoso, Kristen M Chevalier, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor functionKatharine D Grugan, Francis L McCabe, Michelle Kinder, et al.Nature Communications|April 29, 2025
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A virusesAshwin Kumar Ramesh, Jwala Priyadarsini Sivaccumar, Xiaohua Ye, et al.The Biochemical Journal|February 7, 2013
Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1Nicholas T Redpath, Yibin Xu, Nicholas J Wilson, et al.Cell Host & Microbe|April 25, 2023
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infectionsPeter T Buckley, Rita Chan, Jeffrey Fernandez, et al.Emerging Microbes & Infections|December 11, 2023
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoVHailong Guo, Bomsoo Cho, Paul R Hinton, et al.Pageof 3